Last Close
Jun 17  •  02:19PM ET
24.86
Dollar change
-0.26
Percentage change
-1.05
%
Index
RUT
P/E
2617.37
EPS (ttm)
0.01
Insider Own
17.85%
Shs Outstand
106.99M
Perf Week
-0.62%
Market Cap
3.05B
Forward P/E
39.01
EPS next Y
0.64
Insider Trans
-3.14%
Shs Float
100.81M
Perf Month
-13.21%
Enterprise Value
3.00B
PEG
0.96
EPS next Q
0.11
Inst Own
88.72%
Perf Quarter
3.39%
Income
1.35M
P/S
3.43
EPS this Y
35.23%
Inst Trans
1.68%
Perf Half Y
-7.36%
Sales
890.57M
P/B
8.12
EPS next Y
31.10%
ROA
0.19%
Perf YTD
14.11%
Book/sh
3.06
P/C
10.59
EPS next 5Y
40.71%
ROE
0.37%
52W High
31.00 -19.79%
Perf Year
13.90%
Cash/sh
2.35
P/FCF
78.44
EPS past 3/5Y
- -
ROIC
0.23%
52W Low
14.96 66.21%
Perf 3Y
112.70%
Dividend Est.
-
EV/EBITDA
59.75
Sales past 3/5Y
13.39% 17.23%
Gross Margin
51.32%
Volatility
7.00% 7.95%
Perf 5Y
-
Dividend TTM
-
EV/Sales
3.37
EPS Y/Y TTM
109.22%
Oper. Margin
-0.61%
ATR (14)
1.81
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
1.95
Sales Y/Y TTM
12.01%
Profit Margin
0.15%
RSI (14)
49.00
Dividend Gr. 3/5Y
- -
Current Ratio
2.25
EPS Q/Q
-9.32%
SMA20
-0.15%
Beta
1.96
Payout
0.00%
Debt/Eq
0.63
Sales Q/Q
8.34%
SMA50
1.16%
Rel Volume
0.81
Prev Close
25.13
Employees
4036
LT Debt/Eq
0.55
SMA200
3.87%
Avg Volume
2.83M
Price
24.86
IPO
Sep 29, 2021
Option/Short
Yes / Yes
Trades
Volume
1,727,422
Change
-1.05%
Date Action Analyst Rating Change Price Target Change
May-08-26Reiterated Telsey Advisory Group Outperform $32 → $33
Dec-10-25Upgrade Citizens JMP Mkt Perform → Mkt Outperform $30
Nov-07-25Reiterated Telsey Advisory Group Outperform $28 → $24
Aug-01-25Reiterated Telsey Advisory Group Outperform $22 → $28
Jul-10-25Downgrade Citizens JMP Mkt Outperform → Mkt Perform
Apr-30-25Upgrade Citigroup Sell → Neutral $17
Apr-17-25Upgrade Loop Capital Hold → Buy $27
Feb-28-25Reiterated Telsey Advisory Group Outperform $28 → $30
Feb-25-25Initiated ROTH MKM Neutral $26
Feb-05-25Downgrade Citigroup Neutral → Sell $19 → $23
Jun-05-26 07:25PM
May-28-26 08:00AM
May-20-26 11:11AM
May-19-26 05:23PM
01:45PM
01:45PM Loading…
01:45PM
May-13-26 05:52PM
May-08-26 08:30AM
May-07-26 06:45AM
May-06-26 09:23AM
Apr-28-26 08:30AM
Apr-20-26 05:00AM
Apr-16-26 04:05PM
Mar-10-26 12:03AM
Mar-01-26 02:05AM
05:38AM Loading…
Feb-27-26 05:38AM
Feb-26-26 08:10PM
04:11PM
02:15PM
09:55AM
07:32AM
06:54AM
06:45AM
Feb-25-26 07:26AM
Feb-24-26 10:13PM
Feb-17-26 01:02PM
Feb-13-26 03:50PM
Feb-12-26 07:00AM
Feb-10-26 08:49AM
Feb-09-26 04:10PM
08:55PM Loading…
Feb-03-26 08:55PM
05:35PM
Jan-30-26 05:52AM
Jan-28-26 03:01PM
09:02AM
09:02AM
Jan-25-26 10:32PM
Jan-23-26 07:36AM
Jan-14-26 07:09AM
Jan-13-26 11:05PM
Jan-12-26 01:30PM
Jan-06-26 07:31PM
12:29PM
12:29PM
Jan-05-26 12:15PM
Jan-02-26 01:46PM
Dec-23-25 11:48AM
Dec-17-25 01:01PM
Dec-15-25 10:45AM
Dec-14-25 02:41PM
Dec-13-25 07:00AM
Dec-11-25 10:19AM
Dec-10-25 02:09PM
10:35AM
Dec-09-25 04:54PM
02:22PM
02:16PM
11:14AM
11:00AM
Dec-08-25 07:26PM
Nov-26-25 07:00AM
Nov-18-25 01:21PM
Nov-13-25 12:32AM
Nov-12-25 10:38AM
Nov-07-25 09:41AM
09:30AM
Nov-06-25 02:09PM
01:56PM
12:16PM
07:55AM
07:15AM
06:45AM
Nov-05-25 07:31AM
Nov-04-25 10:09PM
Oct-31-25 03:21PM
Oct-16-25 07:00AM
Oct-08-25 12:02AM
Oct-07-25 11:36PM
Oct-05-25 03:53PM
Sep-23-25 05:35AM
Sep-22-25 10:22AM
Sep-16-25 10:43AM
Sep-11-25 09:00AM
Sep-05-25 04:23PM
Aug-28-25 04:05PM
Aug-27-25 10:27PM
09:00AM
Aug-14-25 04:45PM
01:33AM
Aug-13-25 12:05PM
11:24AM
Aug-12-25 09:58AM
03:22AM
Aug-11-25 04:45AM
Aug-10-25 05:30AM
Aug-07-25 02:32PM
09:30AM
08:05AM
07:27AM
06:45AM
Warby Parker, Inc. is an online retailer of eyewear for men and women, which engages in the business of selling eyewear products and providing optical services directly to consumers through its retail stores and e-commerce platform. Its products include eyeglasses, sunglasses and contacts. The company was founded by Neil Blumenthal, Andrew Martin Hunt, Jeffrey J. Raider and David Gilboa on May 7, 2010 and is headquartered in New York, NY.
Co-FounderMr. Neil Harris Blumenthal
Co-FounderMr. David Abraham Gilboa
Co-Founder & Independent DirectorMr. Andrew M. Hunt
Co-Founder & Independent DirectorMr. Jeff Raider
CFO & Principal Accounting OfficerMr. Adrian V. Mitchell
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TERESA BRIGGSDirectorJun 16 '26Proposed Sale26.385,000131,900Jun 16 04:37 PM
Moon Youngme EDirectorJun 12 '26Sale26.5310,000265,30026,061Jun 12 05:13 PM
YOUNGME MOONDirectorJun 12 '26Proposed Sale26.5310,000265,310Jun 12 04:00 PM
Gilboa David AbrahamCo-Chief Executive OfficerJun 02 '26Option Exercise0.0020,799071,092Jun 04 06:20 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJun 02 '26Option Exercise0.0020,799070,964Jun 04 06:18 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerMay 19 '26Sale30.0363,0401,893,09150,165May 21 04:48 PM
NEIL BLUMENTHALDirectorMay 19 '26Proposed Sale28.6563,0401,806,096May 19 04:31 PM
SINGER BRADLEY EDirectorMay 13 '26Sale28.5120,167574,961104,833May 15 09:35 PM
SINGER BRADLEY EDirectorMay 14 '26Sale29.014,833140,205100,000May 15 09:35 PM
Bradley SingerDirectorMay 13 '26Proposed Sale26.9525,000673,750May 13 05:40 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 17 '26Sale24.5675,2131,847,59250,165Apr 20 08:45 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 20 '26Sale25.0922,442563,07050,165Apr 20 08:45 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerApr 16 '26Sale24.082,34556,46850,165Apr 20 08:45 PM
NEIL BLUMENTHALDirectorApr 17 '26Proposed Sale23.1750,0001,158,500Apr 17 04:33 PM
NEIL BLUMENTHALDirectorApr 16 '26Proposed Sale23.6650,0001,183,000Apr 16 04:12 PM
Raider Jeffrey JacobDirectorMar 11 '26Sale25.4325,000635,750448,697Mar 13 06:07 PM
JEFFREY RAIDERDirectorMar 11 '26Proposed Sale25.4325,000635,780Mar 11 04:07 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerMar 05 '26Option Exercise0.0013,475057,618Mar 06 05:13 PM
Gilboa David AbrahamCo-Chief Executive OfficerMar 05 '26Option Exercise0.0013,475057,746Mar 06 05:12 PM
SINGER BRADLEY EDirectorMar 04 '26Sale27.5315,793434,78116,026Mar 06 05:10 PM
BRADLEY SINGERDirectorMar 04 '26Proposed Sale27.5315,793434,824Mar 04 05:35 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 13 '26Sale29.9966019,79337,119Jan 15 06:36 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 13 '26Sale29.4680,0942,359,56937,247Jan 15 06:35 PM
DAVID GILBOADirectorJan 13 '26Proposed Sale26.5880,0942,128,899Jan 13 04:22 PM
NEIL BLUMENTHALDirectorJan 13 '26Proposed Sale26.5866017,543Jan 13 04:21 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 07 '26Sale27.0975,0002,031,75037,247Jan 09 08:48 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 09 '26Sale29.0919,906579,06637,247Jan 09 08:48 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 07 '26Sale27.0850,0001,354,00037,119Jan 09 08:47 PM
DAVID GILBOADirectorJan 09 '26Proposed Sale28.2819,906562,942Jan 09 04:31 PM
NEIL BLUMENTHALDirectorJan 07 '26Proposed Sale25.9450,0001,297,000Jan 07 04:25 PM
DAVID GILBOADirectorJan 07 '26Proposed Sale25.9475,0001,945,500Jan 07 04:24 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJan 06 '26Sale25.09150,0003,763,50037,119Jan 06 08:55 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 06 '26Sale24.2950,0001,214,50037,247Jan 06 08:53 PM
Gilboa David AbrahamCo-Chief Executive OfficerJan 02 '26Sale22.4625,000561,50037,247Jan 06 08:53 PM
NEIL BLUMENTHALDirectorJan 06 '26Proposed Sale23.25150,0003,487,500Jan 06 04:31 PM
DAVID GILBOADirectorJan 06 '26Proposed Sale23.2550,0001,162,500Jan 06 04:28 PM
DAVID GILBOADirectorJan 02 '26Proposed Sale21.7925,000544,750Jan 02 04:33 PM
Cutler Joel EDirectorDec 16 '25Sale26.0119,932518,47720,000Dec 18 04:35 PM
Joel CutlerDirectorDec 16 '25Proposed Sale26.6532,249859,436Dec 16 06:13 PM
Moon Youngme EDirectorDec 11 '25Sale29.0738,8321,128,84627,057Dec 15 05:30 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerDec 11 '25Sale30.29100,0003,029,00037,119Dec 15 05:29 PM
Raider Jeffrey JacobDirectorDec 12 '25Sale27.4225,000685,500483,485Dec 15 05:28 PM
Gilboa David AbrahamCo-Chief Executive OfficerDec 11 '25Sale30.20200,0006,040,00037,247Dec 15 05:27 PM
Warby Parker Impact Foundation10% OwnerDec 15 '25Proposed Sale27.40178,5724,892,873Dec 15 03:16 PM
JEFFREY RAIDEROfficerDec 12 '25Proposed Sale27.4225,000685,618Dec 12 04:28 PM
David GilboaDirectorDec 11 '25Proposed Sale29.57200,0005,914,000Dec 11 04:25 PM
NEIL BLUMENTHALDirectorDec 11 '25Proposed Sale29.57100,0002,957,000Dec 11 04:24 PM
YOUNGME MOONDirectorDec 11 '25Proposed Sale29.0738,8321,128,846Dec 11 04:06 PM
Gilboa David AbrahamCo-Chief Executive OfficerDec 02 '25Option Exercise0.009,816042,677Dec 04 05:03 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerDec 02 '25Option Exercise0.009,816042,549Dec 04 05:02 PM
Gilboa David AbrahamCo-Chief Executive OfficerOct 01 '25Sale27.30125,0003,412,50032,861Oct 03 05:50 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 18 '25Sale27.5858,3601,609,56932,861Sep 19 05:42 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 17 '25Sale27.5260016,51232,861Sep 19 05:42 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 18 '25Sale27.528,416231,60832,733Sep 19 05:40 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 17 '25Sale27.5250013,76032,733Sep 19 05:40 PM
David GilboaDirectorSep 18 '25Proposed Sale26.75175,0004,681,250Sep 18 04:26 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 11 '25Sale27.5341,0401,129,83132,861Sep 15 05:17 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 11 '25Sale27.5341,0841,131,04332,733Sep 15 05:16 PM
NEIL BLUMENTHALDirectorSep 11 '25Proposed Sale27.0150,0001,350,500Sep 11 04:31 PM
David GilboaDirectorSep 11 '25Proposed Sale27.0150,0001,350,500Sep 11 04:31 PM
Cutler Joel EDirectorSep 08 '25Sale26.7535,000936,35219,932Sep 10 08:53 PM
Joel CutlerDirectorSep 08 '25Proposed Sale26.7535,000936,250Sep 08 05:55 PM
Gilboa David AbrahamCo-Chief Executive OfficerSep 03 '25Option Exercise0.009,815038,290Sep 05 05:15 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerSep 03 '25Option Exercise0.009,815038,162Sep 05 05:13 PM
Miller Steven CliveChief Financial OfficerSep 03 '25Option Exercise0.0028,4750248,875Sep 05 05:12 PM
Briggs TeresaDirectorAug 11 '25Sale23.566,000141,36044,879Aug 13 08:22 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerAug 13 '25Sale25.1150,0001,255,50028,347Aug 13 08:19 PM
NEIL BLUMENTHALDirectorAug 13 '25Proposed Sale24.4150,0001,220,500Aug 13 04:22 PM
Teresa BriggsDirectorAug 11 '25Proposed Sale23.566,000141,338Aug 11 04:05 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJul 21 '25Sale24.2149,6001,200,81628,347Jul 22 06:00 PM
Blumenthal Neil HarrisCo-Chief Executive OfficerJul 18 '25Sale24.014009,60428,347Jul 22 06:00 PM
Gilboa David AbrahamCo-Chief Executive OfficerJul 21 '25Sale24.2774,5001,808,11528,475Jul 22 05:58 PM
Gilboa David AbrahamCo-Chief Executive OfficerJul 18 '25Sale24.0150012,00528,475Jul 22 05:58 PM
David GilboaDirectorJul 18 '25Proposed Sale23.4575,0001,758,750Jul 18 04:47 PM
NEIL BLUMENTHALDirectorJul 18 '25Proposed Sale23.4550,0001,172,500Jul 18 04:47 PM
Gilboa David AbrahamCo-Chief Executive OfficerJul 01 '25Sale22.0450,0001,102,00028,475Jul 03 05:00 PM
David GilboaDirectorJul 01 '25Proposed Sale21.9350,0001,096,500Jul 01 04:32 PM
Last Close
Jun 17  •  02:19PM ET
16.42
Dollar change
-1.15
Percentage change
-6.53
%
EYE National Vision Holdings Inc daily Stock Chart
Index
RUT
P/E
28.63
EPS (ttm)
0.57
Insider Own
2.69%
Shs Outstand
80.11M
Perf Week
-6.58%
Market Cap
1.32B
Forward P/E
13.88
EPS next Y
1.18
Insider Trans
0.15%
Shs Float
77.96M
Perf Month
-5.18%
Enterprise Value
1.94B
PEG
0.59
EPS next Q
0.18
Inst Own
119.67%
Perf Quarter
-41.31%
Income
46.59M
P/S
0.65
EPS this Y
20.94%
Inst Trans
2.66%
Perf Half Y
-43.21%
Sales
2.02B
P/B
1.47
EPS next Y
22.29%
ROA
2.31%
Perf YTD
-36.40%
Book/sh
11.21
P/C
19.38
EPS next 5Y
23.72%
ROE
5.37%
52W High
30.02 -45.29%
Perf Year
-26.55%
Cash/sh
0.85
P/FCF
12.46
EPS past 3/5Y
-11.20% -3.46%
ROIC
3.14%
52W Low
14.75 11.34%
Perf 3Y
-36.12%
Dividend Est.
-
EV/EBITDA
11.39
Sales past 3/5Y
-0.30% 3.03%
Gross Margin
54.23%
Volatility
5.50% 5.74%
Perf 5Y
-65.72%
Dividend TTM
-
EV/Sales
0.96
EPS Y/Y TTM
277.28%
Oper. Margin
3.89%
ATR (14)
1.17
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.37
Sales Y/Y TTM
9.20%
Profit Margin
2.31%
RSI (14)
39.83
Dividend Gr. 3/5Y
- -
Current Ratio
0.62
EPS Q/Q
113.74%
SMA20
-2.62%
Beta
1.06
Payout
0.00%
Debt/Eq
0.77
Sales Q/Q
6.58%
SMA50
-19.86%
Rel Volume
1.12
Prev Close
17.57
Employees
13138
LT Debt/Eq
0.65
SMA200
-34.68%
Avg Volume
2.07M
Price
16.42
IPO
Oct 26, 2017
Option/Short
Yes / Yes
Trades
Volume
1,755,974
Change
-6.53%
Date Action Analyst Rating Change Price Target Change
Dec-10-25Initiated Guggenheim Buy $32
Jul-30-25Initiated Roth Capital Buy $36
Jul-08-25Upgrade Barclays Equal Weight → Overweight $30
May-09-25Upgrade Citigroup Neutral → Buy $21
May-07-25Upgrade BofA Securities Underperform → Buy
Oct-17-23Downgrade Goldman Buy → Neutral $25 → $16
Jul-27-23Downgrade Wells Fargo Overweight → Equal Weight $30 → $21
Jul-27-23Downgrade Citigroup Buy → Neutral $28 → $22
May-02-23Downgrade Barclays Overweight → Equal Weight
Mar-31-23Upgrade Loop Capital Hold → Buy $23
May-20-26 07:00AM
May-13-26 07:01PM
05:52PM
04:50PM
06:30AM
06:06AM Loading…
06:06AM
06:00AM
Apr-29-26 07:00AM
Mar-24-26 09:40AM
Mar-23-26 07:00AM
Mar-17-26 07:00AM
Mar-12-26 04:00PM
07:00AM
Mar-10-26 09:05AM
08:00AM
09:40AM Loading…
Mar-05-26 09:40AM
07:43AM
Mar-04-26 04:02PM
03:17PM
12:32PM
10:36AM
09:30AM
07:10AM
06:27AM
06:17AM
06:12AM
06:00AM
Mar-02-26 10:01PM
Feb-26-26 09:55AM
Feb-25-26 09:40AM
08:00AM Loading…
Feb-24-26 08:00AM
Feb-23-26 11:41PM
11:40AM
Feb-20-26 09:50AM
Feb-19-26 10:37AM
Feb-18-26 07:00AM
Feb-16-26 11:39PM
Feb-10-26 11:43AM
11:11AM
Feb-06-26 09:31AM
Feb-05-26 09:25AM
Feb-04-26 12:15PM
09:34AM
Feb-01-26 11:43PM
Jan-30-26 08:05AM
Jan-29-26 08:48AM
Jan-28-26 09:55AM
09:50AM
Jan-27-26 06:25PM
Jan-26-26 12:10PM
Jan-25-26 11:34PM
Jan-22-26 09:49AM
09:40AM
Jan-16-26 07:50AM
Jan-15-26 03:46PM
02:36PM
Jan-13-26 07:00AM
Jan-11-26 11:31PM
Jan-07-26 06:07PM
11:46AM
Jan-06-26 04:05PM
Dec-30-25 11:31PM
Dec-19-25 09:09AM
Dec-18-25 11:32PM
11:30AM
Dec-16-25 10:36PM
Dec-10-25 11:03PM
Dec-05-25 11:30AM
Nov-26-25 08:00AM
Nov-18-25 02:15PM
Nov-17-25 06:45AM
Nov-12-25 12:32AM
Nov-06-25 06:00PM
09:30AM
12:31AM
Nov-05-25 12:25PM
07:20AM
06:25AM
06:16AM
06:00AM
Nov-03-25 10:23PM
Oct-31-25 07:10AM
Oct-28-25 12:01AM
Oct-22-25 08:00AM
Oct-09-25 11:31PM
Oct-07-25 09:01AM
Oct-01-25 12:39AM
Sep-30-25 12:32AM
Sep-25-25 09:31AM
Sep-19-25 05:09AM
Sep-02-25 04:40PM
Aug-20-25 08:00AM
Aug-19-25 09:00AM
Aug-13-25 01:35AM
Aug-12-25 08:22AM
03:06AM
Aug-08-25 03:43PM
Aug-07-25 01:00PM
Aug-06-25 07:10AM
06:19AM
National Vision Holdings, Inc. engages in the retail of optical products. It operates through the following segments: Owned and Host, Legacy, and Corporate and Other. The Owned and Host segment offers America's Best and Eyeglass World brands. The Legacy segment includes inventory and lab processing services. The Corporate and Other segment relates to the results of operations of the other operating segments and corporate overhead support. The company was founded in 1990 and is headquartered in Duluth, GA.
Executive Chairman of the BoardMr. L. Reade Fahs
CEO & DirectorMr. Alexander N. Wilkes
Chief Financial OfficerMr. Christopher Laden
Senior VPMr. Jared Brandman J.D.
Senior VP & Chief People OfficerMr. Bill Clark
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Nicholson Michael JDirectorJun 05 '26Buy15.5250,000776,00050,000Jun 09 04:55 PM
Wilkes AlexanderChief Executive OfficerMar 11 '26Sale26.5435,000928,90016,431Mar 12 04:15 PM
Wilkes AlexanderOfficerMar 11 '26Proposed Sale27.3035,000955,500Mar 11 10:59 AM
FAHS L READEExecutive ChairmanMar 06 '26Sale29.587,601224,838694,880Mar 09 04:19 PM
FAHS L READEExecutive ChairmanMar 06 '26Sale29.574,071120,379359,359Mar 09 04:19 PM
FAHS L READEMember of immediate family of Mar 06 '26Proposed Sale29.574,071120,391Mar 06 04:35 PM
FAHS L READEOfficerMar 06 '26Proposed Sale29.587,601224,862Mar 06 04:32 PM
Patel Priti VHead of Emerging BrandsMar 03 '26Option Exercise0.0011,951029,720Mar 04 04:24 PM
VanDette JosephChief Brand & Mktg OfficerMar 03 '26Option Exercise0.0025,394047,780Mar 04 04:24 PM
Clark BillSVP, Chief People OfficerMar 03 '26Option Exercise0.0025,394071,926Mar 04 04:23 PM
Brandman JaredChief Legal & Strategy OfficerMar 03 '26Option Exercise0.0025,394076,748Mar 04 04:23 PM
FAHS L READEExecutive ChairmanMar 03 '26Option Exercise0.00179,2480751,914Mar 04 04:22 PM
FAHS L READEExecutive ChairmanSep 16 '25Sale23.9310,598253,610532,195Sep 17 04:11 PM
FAHS L READEExecutive ChairmanSep 15 '25Sale23.812,00247,668542,793Sep 17 04:11 PM
FAHS L READEOfficerSep 16 '25Proposed Sale23.9310,598253,629Sep 16 04:16 PM
FAHS L READEOfficerSep 15 '25Proposed Sale23.812,00247,670Sep 15 04:12 PM
FAHS L READEExecutive ChairmanAug 28 '25Sale24.33137,4003,343,174544,795Aug 29 04:16 PM
FAHS L READEOfficerAug 28 '25Proposed Sale24.33137,4003,343,335Aug 28 04:16 PM
Last Close
Jun 17  •  02:19PM ET
29.26
Dollar change
+0.34
Percentage change
1.17
%
STAA Staar Surgical Co daily Stock Chart
Index
RUT
P/E
-
EPS (ttm)
-0.43
Insider Own
39.70%
Shs Outstand
49.40M
Perf Week
-0.25%
Market Cap
1.46B
Forward P/E
30.58
EPS next Y
0.96
Insider Trans
5.92%
Shs Float
30.02M
Perf Month
-9.45%
Enterprise Value
1.33B
PEG
-
EPS next Q
0.22
Inst Own
75.47%
Perf Quarter
57.47%
Income
-21.03M
P/S
5.02
EPS this Y
171.29%
Inst Trans
-7.31%
Perf Half Y
24.19%
Sales
290.38M
P/B
4.10
EPS next Y
34.18%
ROA
-4.63%
Perf YTD
26.71%
Book/sh
7.13
P/C
8.89
EPS next 5Y
-
ROE
-5.99%
52W High
35.87 -18.43%
Perf Year
75.94%
Cash/sh
3.29
P/FCF
-
EPS past 3/5Y
- -
ROIC
-5.48%
52W Low
15.59 87.73%
Perf 3Y
-44.39%
Dividend Est.
-
EV/EBITDA
38.45
Sales past 3/5Y
-5.57% 7.93%
Gross Margin
75.13%
Volatility
2.86% 3.98%
Perf 5Y
-80.64%
Dividend TTM
-
EV/Sales
4.58
EPS Y/Y TTM
70.55%
Oper. Margin
9.05%
ATR (14)
1.22
Perf 10Y
435.86%
Dividend Ex-Date
-
Quick Ratio
4.31
Sales Y/Y TTM
4.03%
Profit Margin
-7.24%
RSI (14)
51.12
Dividend Gr. 3/5Y
- -
Current Ratio
5.12
EPS Q/Q
109.31%
SMA20
-2.66%
Beta
1.23
Payout
-
Debt/Eq
0.11
Sales Q/Q
119.59%
SMA50
3.87%
Rel Volume
0.23
Prev Close
28.92
Employees
957
LT Debt/Eq
0.09
SMA200
19.97%
Avg Volume
1.08M
Price
29.26
IPO
Jul 07, 1983
Option/Short
Yes / Yes
Trades
Volume
185,848
Change
1.17%
Date Action Analyst Rating Change Price Target Change
May-14-26Upgrade Wedbush Neutral → Outperform $40
Apr-09-26Upgrade Canaccord Genuity Hold → Buy $27
Feb-03-26Initiated Wedbush Neutral $26
Jan-16-26Resumed Morgan Stanley Underweight $13
Apr-21-25Initiated Wells Fargo Equal Weight $17
Feb-12-25Downgrade William Blair Outperform → Mkt Perform
Feb-12-25Downgrade Mizuho Outperform → Neutral $45 → $17
Feb-12-25Downgrade Jefferies Buy → Hold
Feb-12-25Downgrade BTIG Research Buy → Neutral
Jul-15-24Downgrade Morgan Stanley Equal-Weight → Underweight $50 → $37
May-21-26 04:01PM
May-20-26 03:33PM
May-14-26 09:45AM
01:03AM
May-13-26 04:13PM
04:01PM Loading…
04:01PM
May-04-26 04:01PM
Apr-09-26 01:32PM
06:26AM
Apr-08-26 04:01PM
Mar-17-26 06:57AM
Mar-04-26 08:30AM
12:02AM
Mar-03-26 07:02PM
05:15PM
04:34PM Loading…
04:34PM
04:21PM
04:02PM
04:01PM
Mar-02-26 09:36AM
Feb-26-26 05:30PM
Feb-25-26 04:01PM
Feb-24-26 12:31PM
08:31AM
Feb-23-26 04:01PM
08:46AM
08:45AM
Feb-19-26 12:08PM
Feb-18-26 05:18AM
Feb-17-26 04:01PM
11:37PM Loading…
Feb-09-26 11:37PM
Feb-05-26 10:00AM
07:55AM
Feb-04-26 01:27PM
Feb-03-26 10:00AM
09:34AM
05:23AM
Feb-02-26 12:55PM
07:00AM
Jan-30-26 01:00PM
Jan-25-26 08:18PM
Jan-23-26 04:35PM
Jan-16-26 08:39PM
09:32AM
08:02AM
05:00AM
Jan-15-26 11:04PM
01:06PM
08:30AM
Jan-13-26 08:45AM
Jan-07-26 07:38AM
Jan-06-26 08:00PM
12:32PM
12:14PM
09:52AM
08:47AM
06:13AM
Dec-19-25 03:51PM
12:59PM
11:45AM
Dec-17-25 06:47PM
04:53PM
01:17PM
10:55AM
Dec-16-25 03:58PM
01:32PM
09:12AM
07:00AM
Dec-15-25 06:35PM
Dec-12-25 05:29PM
08:40AM
Dec-11-25 08:06PM
11:41AM
09:47AM
07:00AM
Dec-10-25 01:34PM
07:05AM
Dec-09-25 02:25PM
02:16PM
12:39PM
12:00PM
08:30AM
Dec-08-25 04:11PM
01:28PM
08:16AM
08:00AM
Dec-04-25 10:35PM
Dec-03-25 12:02PM
Dec-02-25 04:14PM
Nov-26-25 03:34PM
Nov-18-25 04:15PM
Nov-12-25 02:35PM
Nov-10-25 06:38PM
01:00PM
08:00AM
Nov-07-25 04:22PM
10:10AM
Nov-06-25 06:21AM
Nov-05-25 04:27PM
04:01PM
STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The firm offers implantable lenses for the eye and accessory delivery systems. Its products include refractive and cataract solutions through the Collamer brand. The company was founded in 1982 and is headquartered in Lake Forest, CA.
Interim Co-CEO & CFOMs. Deborah J. Andrews
Interim Co-CEOMr. Warren Foust
Chief Development OfficerDr. Magda Michna Ph.D.
Director of Investor RelationsMs. Connie Johnson
VPMs. Kathleen Determann J.D.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Foust WarrenInterim Co-CEO and Pres. & COOMar 14 '26Option Exercise0.0029,325063,588Mar 16 05:00 PM
Foust WarrenInterim Co-CEO and Pres. & COOMar 12 '26Option Exercise0.008,175034,263Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 14 '26Option Exercise0.0017,595036,001Mar 16 05:00 PM
Michna MagdaChief Development OfficerMar 12 '26Option Exercise0.006,178020,622Mar 16 05:00 PM
BROADWOOD PARTNERS, L.P.DirectorMar 13 '26Buy18.61316,0175,882,65616,123,842Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 12 '26Buy18.12299,4325,424,33015,807,825Mar 13 07:59 PM
BROADWOOD PARTNERS, L.P.DirectorMar 11 '26Buy17.5254,764959,55815,508,393Mar 13 07:59 PM
Jiang WeiDirectorJan 12 '26Option Exercise0.0020,967066,444Jan 14 05:48 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 09 '26Buy22.0527,485606,13815,453,629Jan 13 09:30 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 06 '26Buy21.62336,9467,284,28115,356,437Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 07 '26Buy22.0066,4671,462,30115,422,904Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerJan 08 '26Buy21.943,24071,08215,426,144Jan 08 07:31 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 21 '25Buy27.86797,48622,218,83715,019,491Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 20 '25Buy27.14393,38210,675,32514,222,005Nov 21 09:55 PM
BROADWOOD PARTNERS, L.P.10% OwnerNov 19 '25Buy26.42309,1328,166,15513,828,623Nov 21 09:55 PM
Jiang WeiDirectorNov 12 '25Option Exercise0.0020,967045,477Nov 14 06:00 PM
Jiang WeiDirectorAug 12 '25Option Exercise0.0020,967024,510Aug 13 06:39 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.871,75047,025Aug 05 06:38 PM
WEISNER AIMEE SFormer DirectorAug 05 '25Proposed Sale26.8713,491362,523Aug 05 06:33 PM
Last Close
Jun 17  •  02:19PM ET
14.94
Dollar change
-0.05
Percentage change
-0.33
%
BLCO Bausch + Lomb Corp daily Stock Chart
Index
-
P/E
-
EPS (ttm)
-0.62
Insider Own
88.85%
Shs Outstand
356.40M
Perf Week
-2.10%
Market Cap
5.33B
Forward P/E
13.92
EPS next Y
1.07
Insider Trans
0.02%
Shs Float
39.77M
Perf Month
-7.26%
Enterprise Value
10.19B
PEG
0.35
EPS next Q
0.15
Inst Own
9.98%
Perf Quarter
-6.74%
Income
-219.00M
P/S
1.02
EPS this Y
58.04%
Inst Trans
-1.09%
Perf Half Y
-12.58%
Sales
5.21B
P/B
0.83
EPS next Y
33.20%
ROA
-1.61%
Perf YTD
-12.53%
Book/sh
17.90
P/C
19.09
EPS next 5Y
39.39%
ROE
-3.44%
52W High
18.92 -21.02%
Perf Year
29.02%
Cash/sh
0.78
P/FCF
6193.78
EPS past 3/5Y
- -
ROIC
-1.92%
52W Low
11.44 30.59%
Perf 3Y
-23.78%
Dividend Est.
-
EV/EBITDA
14.08
Sales past 3/5Y
10.62% 8.38%
Gross Margin
55.86%
Volatility
2.65% 2.44%
Perf 5Y
-
Dividend TTM
-
EV/Sales
1.96
EPS Y/Y TTM
39.85%
Oper. Margin
5.91%
ATR (14)
0.41
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
0.99
Sales Y/Y TTM
7.85%
Profit Margin
-4.21%
RSI (14)
37.95
Dividend Gr. 3/5Y
- -
Current Ratio
1.53
EPS Q/Q
66.73%
SMA20
-3.13%
Beta
0.58
Payout
-
Debt/Eq
0.79
Sales Q/Q
9.41%
SMA50
-5.98%
Rel Volume
0.94
Prev Close
14.99
Employees
13000
LT Debt/Eq
0.79
SMA200
-7.42%
Avg Volume
456.79K
Price
14.94
IPO
May 06, 2022
Option/Short
Yes / Yes
Trades
Volume
325,270
Change
-0.33%
Date Action Analyst Rating Change Price Target Change
Jan-05-26Downgrade Evercore ISI Outperform → In-line $18
Dec-11-25Upgrade Citigroup Neutral → Buy $20
Dec-02-25Upgrade Morgan Stanley Equal-Weight → Overweight $21
Oct-01-25Initiated Goldman Neutral $16
May-02-25Reiterated H.C. Wainwright Buy $20 → $15
Mar-28-25Downgrade Wells Fargo Overweight → Equal Weight $24 → $15
Dec-11-24Downgrade Citigroup Buy → Neutral $24 → $22
Dec-02-24Downgrade Morgan Stanley Overweight → Equal-Weight $19
Oct-15-24Upgrade Evercore ISI In-line → Outperform $19 → $25
Jul-10-24Initiated Raymond James Outperform $19
Jun-10-26 06:00AM
05:12AM
Jun-01-26 06:59AM
May-21-26 07:15AM
May-20-26 04:49PM
07:00AM Loading…
May-19-26 07:00AM
May-07-26 07:00AM
May-06-26 07:15AM
Apr-30-26 08:30AM
07:00AM
03:18AM
Apr-29-26 07:07AM
06:58AM
Apr-23-26 07:00AM
Apr-22-26 07:15AM
07:00AM Loading…
Apr-16-26 07:00AM
Apr-08-26 07:00AM
Apr-07-26 07:00AM
Apr-06-26 07:00AM
Mar-30-26 07:15AM
Mar-23-26 07:00AM
Mar-11-26 06:00AM
Mar-09-26 07:15AM
Feb-27-26 12:57PM
05:14AM
Feb-25-26 12:36AM
Feb-24-26 07:00AM
Feb-19-26 12:00PM
12:31AM
Feb-18-26 10:11PM
04:31PM Loading…
04:31PM
02:58PM
02:23PM
02:00PM
01:25PM
01:25PM
09:36AM
09:30AM
08:10AM
07:37AM
07:19AM
06:58AM
Feb-16-26 10:07PM
09:15AM
Feb-12-26 08:50AM
Feb-11-26 09:30AM
Feb-09-26 11:02PM
11:40AM
Jan-29-26 11:34PM
Jan-23-26 11:40AM
Jan-20-26 07:15AM
Jan-05-26 07:00AM
Jan-02-26 04:30PM
Dec-23-25 07:30AM
Dec-17-25 04:30PM
Dec-12-25 04:48PM
Dec-11-25 11:41AM
Dec-04-25 10:09PM
Dec-02-25 11:10AM
Nov-18-25 04:30PM
Nov-13-25 02:57PM
08:55AM
08:41AM
Nov-10-25 06:59AM
04:28AM
Nov-05-25 12:35AM
Nov-03-25 04:30PM
Oct-30-25 01:34AM
Oct-29-25 03:47PM
09:30AM
08:05AM
07:23AM
07:06AM
06:58AM
Oct-28-25 09:26AM
Oct-27-25 11:12PM
Oct-20-25 06:44PM
11:36AM
09:34AM
07:41AM
07:25AM
Oct-19-25 08:00PM
Oct-17-25 12:24PM
Oct-10-25 06:44PM
Oct-02-25 11:40AM
Oct-01-25 11:01AM
Sep-25-25 01:06PM
Sep-11-25 07:00AM
Sep-09-25 07:00AM
Sep-08-25 06:56PM
04:30PM
07:00AM
Sep-05-25 12:41AM
Aug-22-25 02:25PM
Aug-20-25 11:31PM
Aug-18-25 05:48PM
05:01PM
Aug-14-25 07:15AM
Aug-12-25 11:55PM
11:48PM
Bausch + Lomb Corp. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company operates its business through three segments: Vision Care/Consumer Health Care, Ophthalmic Pharmaceuticals and Surgical. The Vision Care/Consumer Health Care segment includes both contact lens and consumer eye care businesses. The Ophthalmic Pharmaceuticals segment consists of a broad line of proprietary pharmaceutical products for post-operative treatments and treatments for a number of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes and retinal diseases. The Surgical segment consists of medical device equipment, consumables and instrumental tools and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions, and includes IOLs and delivery systems, phacoemulsification equipment and other surgical instruments and devices necessary for cataract surgery. Bausch + Lomb was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Vaughan, Canada.
CEO & ChairmanMr. Brenton L. Saunders J.D.
Executive VP & CFOMr. Osama A. Eldessouky
Executive VP & Chief Legal OfficerMr. A. Robert D. Bailey
Ph.D.Dr. Yehia Hashad M.D.
President of Global Pharmaceuticals & International ConsumerMr. Andrew J. Stewart
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Bailey A Robert DEVP & Chief Legal OfficerMar 06 '26Buy17.1514,600250,332231,890Mar 10 05:23 PM
Eldessouky SamEVP and CFOMar 06 '26Buy17.134,00068,520403,130Mar 10 04:34 PM
SAUNDERS BRENT LCEO and Chairman of the BoardMar 06 '26Buy17.1414,700251,958966,575Mar 10 04:32 PM
Ross Thomas W. Sr.DirectorMar 03 '26Buy17.684,50079,55664,891Mar 04 04:18 PM
Alfonso EduardoDirectorMar 02 '26Buy17.904,30076,9709,555Mar 03 04:26 PM
VON ESCHENBACH ANDREW C.DirectorFeb 27 '26Buy18.304,36479,88366,450Mar 03 04:24 PM
COLLIS STEVEN HDirectorFeb 23 '26Buy17.8115,000267,15020,255Feb 24 04:23 PM
ROBERTSON RUSSEL CDirectorFeb 20 '26Buy17.904,40078,76072,407Feb 24 04:16 PM
Ling KarenDirectorFeb 19 '26Buy17.744,00070,96841,676Feb 23 04:20 PM
Last Close
Jun 17  •  02:14PM ET
0.8716
Dollar change
+0.0111
Percentage change
1.29
%
LUCY Innovative Eyewear Inc daily Stock Chart
Index
-
P/E
-
EPS (ttm)
-1.74
Insider Own
10.05%
Shs Outstand
6.30M
Perf Week
-1.04%
Market Cap
5.58M
Forward P/E
-
EPS next Y
-0.42
Insider Trans
0.83%
Shs Float
5.76M
Perf Month
-7.29%
Enterprise Value
-0.05M
PEG
-
EPS next Q
-0.37
Inst Own
9.03%
Perf Quarter
-21.48%
Income
-8.12M
P/S
1.87
EPS this Y
35.26%
Inst Trans
5.09%
Perf Half Y
-38.18%
Sales
2.98M
P/B
0.66
EPS next Y
65.85%
ROA
-93.24%
Perf YTD
-12.53%
Book/sh
1.33
P/C
0.98
EPS next 5Y
-
ROE
-102.40%
52W High
4.97 -82.46%
Perf Year
-62.91%
Cash/sh
0.89
P/FCF
-
EPS past 3/5Y
50.36% 1.99%
ROIC
-96.81%
52W Low
0.86 1.63%
Perf 3Y
-98.01%
Dividend Est.
-
EV/EBITDA
-
Sales past 3/5Y
59.19% 115.71%
Gross Margin
17.52%
Volatility
5.31% 4.70%
Perf 5Y
-
Dividend TTM
-
EV/Sales
-0.02
EPS Y/Y TTM
60.81%
Oper. Margin
-300.70%
ATR (14)
0.04
Perf 10Y
-
Dividend Ex-Date
-
Quick Ratio
6.09
Sales Y/Y TTM
74.57%
Profit Margin
-272.48%
RSI (14)
33.52
Dividend Gr. 3/5Y
- -
Current Ratio
8.02
EPS Q/Q
49.01%
SMA20
-7.77%
Beta
2.68
Payout
-
Debt/Eq
0.01
Sales Q/Q
70.20%
SMA50
-13.00%
Rel Volume
0.26
Prev Close
0.86
Employees
13
LT Debt/Eq
0.00
SMA200
-35.78%
Avg Volume
80.38K
Price
0.87
IPO
Aug 15, 2022
Option/Short
No / Yes
Trades
Volume
15,631
Change
1.29%
May-14-26 04:47PM
08:00AM
Apr-22-26 08:00AM
Apr-17-26 08:00AM
Apr-16-26 08:00AM
08:00AM Loading…
Apr-10-26 08:00AM
Mar-31-26 08:00AM
Mar-30-26 09:00PM
Mar-25-26 04:30PM
Mar-10-26 04:30PM
Feb-24-26 08:00AM
Feb-17-26 08:30AM
Jan-22-26 08:30AM
Jan-09-26 12:57PM
Jan-07-26 08:34PM
08:00AM Loading…
08:00AM
Dec-22-25 08:00AM
Dec-11-25 08:06AM
Nov-13-25 08:00AM
Nov-04-25 08:30AM
Oct-06-25 08:00AM
Sep-24-25 08:00AM
Sep-10-25 08:30AM
Aug-14-25 04:30PM
Aug-11-25 08:00AM
Jul-21-25 08:30AM
Jun-24-25 03:27PM
Jun-23-25 07:00AM
Jun-20-25 08:30AM
May-29-25 08:00AM
05:49PM Loading…
May-13-25 05:49PM
May-05-25 08:00AM
Apr-28-25 08:00AM
Apr-23-25 08:30AM
Apr-11-25 09:00AM
Apr-10-25 08:30AM
Apr-07-25 08:30AM
Mar-25-25 08:30AM
Feb-26-25 08:30AM
Feb-05-25 08:30AM
Jan-30-25 08:30AM
Jan-16-25 08:30AM
Jan-15-25 08:30AM
Dec-16-24 10:55PM
Nov-25-24 08:30AM
Nov-13-24 08:00AM
Nov-05-24 08:30AM
Oct-29-24 08:30AM
Oct-24-24 08:30AM
Oct-14-24 08:30AM
Oct-02-24 12:07PM
Sep-25-24 08:20PM
Sep-23-24 08:00AM
Sep-17-24 08:30AM
Sep-05-24 08:30AM
Sep-04-24 05:49PM
Sep-03-24 08:39AM
Aug-29-24 08:00AM
Aug-21-24 08:00AM
Aug-13-24 08:00AM
Aug-01-24 10:22AM
Jul-18-24 08:00AM
Jun-14-24 08:30AM
Jun-13-24 08:30AM
Jun-07-24 06:40AM
Jun-03-24 08:00AM
May-30-24 07:47AM
May-29-24 04:15PM
12:15PM
11:58AM
09:00AM
07:39AM
May-28-24 02:43PM
07:27AM
May-24-24 04:02PM
07:16AM
May-14-24 01:53PM
08:30AM
May-01-24 05:00PM
04:30PM
Apr-29-24 08:00AM
Apr-25-24 08:32AM
Apr-24-24 08:30AM
Apr-18-24 08:30AM
Apr-17-24 08:30AM
Mar-25-24 01:53PM
08:30AM
Feb-01-24 09:00AM
Jan-22-24 08:00AM
Jan-11-24 08:00AM
Jan-10-24 08:00AM
Jan-05-24 10:04AM
Dec-14-23 08:30AM
Dec-13-23 09:00AM
Dec-12-23 08:30AM
Dec-11-23 08:30AM
Nov-16-23 07:00AM
Oct-17-23 07:00AM
Oct-03-23 08:00AM
Sep-22-23 03:05PM
Innovative Eyewear, Inc. retails eye glasses online. It designs and provides smart glasses enhanced with tech features such as built-in Bluetooth audio connectivity, phone control buttons and instant AI voice assistant access. The company was founded by Harrison Gross, Konrad Dabrowski and David Eric Cohen in 2019 and is headquartered in Miami, FL.
Co-FounderMr. Harrison Reed Gross
Co-Founder and Chief AI & Growth OfficerMr. Konrad Dabrowski
Co-Founder & CTOMr. David Eric Cohen
Chief Financial OfficerMr. Oswald Anthony Gayle
Chief Operating OfficerMr. Jaoquin Abondano
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dabrowski KonradOfficerApr 02 '26Proposed Sale1.0520,90021,945May 12 03:08 PM
Gross Harrison R.OfficerApr 02 '26Proposed Sale1.0524,60025,830Apr 07 11:35 AM
Abondano JoaquinOfficerApr 02 '26Proposed Sale1.0514,80015,540Apr 02 04:50 PM
Cohen David EricOfficerApr 02 '26Proposed Sale1.0518,20019,110Apr 02 04:37 PM
Gayle OswaldOfficerApr 02 '26Proposed Sale1.0516,23317,045Apr 02 02:57 PM
Gross Harrison R.Chief Executive OfficerJan 21 '26Buy1.321,5001,98013,733Jan 22 11:29 AM
Gayle OswaldChief Financial OfficerJan 13 '26Buy1.671,0001,6692,865Jan 15 05:00 PM
Gross Harrison R.Chief Executive OfficerJan 08 '26Buy1.601,5002,40012,233Jan 12 05:00 PM
Dabrowski KonradChief AI & Growth OfficerJan 08 '26Buy1.581,3002,05412,804Jan 12 05:00 PM
Galkin Vladimir10% OwnerDec 04 '25Proposed Sale1.471,000,0001,470,000Dec 05 03:54 PM
Cohen David EricOfficerSep 24 '25Proposed Sale2.167591,641Sep 25 12:38 PM
Gayle OswaldOfficerSep 23 '25Proposed Sale2.253,7308,410Sep 24 11:46 AM
Cohen David EricOfficerSep 10 '25Proposed Sale2.127601,611Sep 10 02:40 PM
Dabrowski KonradOfficerAug 19 '25Proposed Sale1.952,5965,058Aug 19 01:22 PM
Abondano JoaquinOfficerAug 19 '25Proposed Sale1.951,4852,890Aug 19 01:17 PM
Gross Harrison R.OfficerAug 19 '25Proposed Sale1.963,0095,894Aug 19 01:12 PM
Cohen David EricOfficerAug 19 '25Proposed Sale1.992,2254,422Aug 19 11:02 AM
Gayle OswaldOfficerAug 19 '25Proposed Sale1.991,6703,317Aug 19 10:58 AM
Last Close
Jun 17  •  02:19PM ET
65.67
Dollar change
-1.68
Percentage change
-2.49
%
COO Cooper Companies Inc daily Stock Chart
Index
S&P 500
P/E
55.46
EPS (ttm)
1.18
Insider Own
0.67%
Shs Outstand
194.90M
Perf Week
-2.98%
Market Cap
12.81B
Forward P/E
13.09
EPS next Y
5.02
Insider Trans
0.37%
Shs Float
193.73M
Perf Month
7.76%
Enterprise Value
15.13B
PEG
1.30
EPS next Q
1.12
Inst Own
105.76%
Perf Quarter
-7.73%
Income
235.80M
P/S
3.03
EPS this Y
12.41%
Inst Trans
0.68%
Perf Half Y
-19.45%
Sales
4.23B
P/B
1.55
EPS next Y
8.31%
ROA
1.89%
Perf YTD
-19.88%
Book/sh
42.27
P/C
92.14
EPS next 5Y
10.04%
ROE
2.85%
52W High
89.83 -26.90%
Perf Year
-4.49%
Cash/sh
0.71
P/FCF
22.49
EPS past 3/5Y
-1.15% 9.30%
ROIC
2.33%
52W Low
58.89 11.51%
Perf 3Y
-28.50%
EV/EBITDA
13.11
Sales past 3/5Y
7.35% 10.98%
Gross Margin
60.93%
Volatility
2.09% 2.62%
Perf 5Y
-31.21%
EV/Sales
3.58
EPS Y/Y TTM
-42.65%
Oper. Margin
18.19%
ATR (14)
1.83
Perf 10Y
62.26%
Quick Ratio
0.78
Sales Y/Y TTM
6.09%
Profit Margin
5.57%
RSI (14)
53.83
Current Ratio
1.27
EPS Q/Q
-191.42%
SMA20
2.54%
Beta
0.85
Debt/Eq
0.30
Sales Q/Q
7.90%
SMA50
1.93%
Rel Volume
1.03
Prev Close
67.35
Employees
15000
LT Debt/Eq
0.23
SMA200
-9.63%
Avg Volume
2.55M
Price
65.67
IPO
Jan 21, 1983
Option/Short
Yes / Yes
Trades
Volume
1,979,417
Change
-2.49%
Date Action Analyst Rating Change Price Target Change
Jun-05-26Reiterated Needham Buy $101 → $86
Mar-04-26Downgrade Rothschild & Co Redburn Buy → Neutral $85
Feb-03-26Reiterated Needham Buy $100 → $99
Nov-13-25Downgrade Wells Fargo Overweight → Equal Weight $72
Oct-13-25Initiated Barclays Overweight $85
Oct-01-25Initiated Goldman Sell $64
Aug-28-25Downgrade Citigroup Buy → Neutral $72
Jul-22-25Upgrade BNP Paribas Exane Neutral → Outperform $92
Jun-17-25Upgrade Needham Hold → Buy $94
May-30-25Downgrade JP Morgan Overweight → Neutral $76
Jun-05-26 12:00PM
01:00AM
Jun-04-26 04:15PM
May-29-26 08:05AM
May-13-26 05:52PM
04:15PM Loading…
May-04-26 04:15PM
Apr-30-26 04:15PM
Apr-09-26 08:05AM
Mar-17-26 08:19AM
Mar-13-26 11:55AM
Mar-09-26 05:24PM
09:40AM
09:15AM
Mar-07-26 08:15AM
Mar-06-26 04:42PM
12:45PM Loading…
12:45PM
11:18AM
10:45AM
10:05AM
09:45AM
09:20AM
09:14AM
08:30AM
06:29AM
03:05AM
12:01AM
Mar-05-26 08:18PM
06:00PM
05:30PM
04:33PM
04:15PM Loading…
04:15PM
Mar-04-26 09:39AM
07:59AM
07:54AM
Mar-03-26 05:15PM
Mar-02-26 09:36AM
09:15AM
Feb-26-26 10:00AM
Feb-25-26 08:28AM
Feb-24-26 07:30PM
12:31PM
08:31AM
Feb-23-26 08:46AM
08:45AM
Feb-18-26 07:42AM
Feb-17-26 01:44PM
09:27AM
Feb-13-26 11:40AM
Feb-11-26 01:34PM
Feb-10-26 09:23AM
Feb-05-26 04:15PM
Feb-04-26 05:20PM
Feb-03-26 01:17PM
12:10PM
08:05AM
Feb-02-26 11:57AM
Jan-29-26 11:38PM
12:17PM
Jan-28-26 11:40AM
Jan-27-26 12:19PM
09:45AM
Jan-26-26 09:40AM
Jan-23-26 01:50PM
07:57AM
Jan-22-26 11:08AM
10:43AM
Jan-21-26 11:43AM
Jan-14-26 12:50PM
Jan-13-26 11:16AM
Jan-12-26 11:40AM
Jan-07-26 03:00PM
Jan-06-26 08:00AM
Jan-05-26 07:17AM
Jan-01-26 10:32PM
Dec-31-25 07:36AM
Dec-30-25 02:04PM
07:33AM
Dec-29-25 04:15PM
Dec-26-25 11:40AM
Dec-23-25 08:00AM
Dec-22-25 12:12PM
Dec-19-25 09:55AM
Dec-16-25 11:05PM
11:37AM
Dec-12-25 09:50AM
Dec-11-25 07:34AM
12:31AM
Dec-10-25 11:40AM
Dec-08-25 09:40AM
09:15AM
Dec-05-25 11:11AM
11:02AM
09:11AM
07:36AM
02:46AM
12:31AM
12:02AM
Dec-04-25 06:30PM
05:25PM
04:45PM
The Cooper Cos, Inc. operates as a medical device company. It operates through the Cooper Vision and Cooper Surgical segments. The Cooper Vision segment develops, manufactures, and markets products for contact lens wearers, which solves vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues. The Cooper Surgical segment focuses on the provision of advancement for the health of women, babies, and families through women's health and fertility products and services. The company was founded in 1958 and is headquartered in San Ramon, CA.
PresidentMr. Albert G. White III
Executive VPMr. Brian G. Andrews
Executive VPMr. Daniel G. McBride Esq.
President of CooperSurgicalMs. Holly R. Sheffield
President of CooperVisionMr. Gerard H. Warner III
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Rosebrough Walter M JrDirectorApr 01 '26Option Exercise0.008320832Apr 21 05:45 PM
WEISS ROBERT SDirectorApr 01 '26Option Exercise0.003,6540292,599Apr 06 05:16 PM
Rivas MariaDirectorApr 01 '26Option Exercise0.003,32203,322Apr 06 05:16 PM
Jay ColleenDirectorApr 01 '26Option Exercise0.003,322039,907Apr 06 05:16 PM
Carbone BarbaraDirectorApr 01 '26Option Exercise0.003,05003,050Apr 06 05:15 PM
MADDEN TERESA SDirectorApr 01 '26Option Exercise0.003,322015,679Apr 06 05:15 PM
Lucchese Cynthia LDirectorApr 01 '26Option Exercise0.003,322012,767Apr 06 05:14 PM
Kurzius Lawrence ErikDirectorApr 01 '26Option Exercise0.003,322011,099Apr 06 05:14 PM
Jay ColleenDirectorJan 12 '26Option Exercise39.407,064278,32236,585Jan 14 04:05 PM
White Albert G IIIPresident & CEOJan 08 '26Option Exercise0.0018,3400254,491Jan 12 04:24 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Jan 08 '26Option Exercise0.0011,518029,837Jan 12 04:24 PM
Sheffield Holly RPresident, CSIJan 08 '26Option Exercise0.008,050047,102Jan 12 04:23 PM
McBride Daniel GEVP & Chief Operating OfficerJan 08 '26Option Exercise0.0012,887076,007Jan 12 04:23 PM
Andrews Brian GEVP, CFO & TreasurerJan 08 '26Option Exercise0.003,528010,430Jan 12 04:22 PM
Lucchese Cynthia LDirectorDec 22 '25Buy84.061,784149,9639,445Dec 23 04:08 PM
Rivas MariaDirectorDec 18 '25Buy82.131,00082,13011,141Dec 19 04:18 PM
Kurzius Lawrence ErikDirectorDec 17 '25Buy82.502,000165,0007,777Dec 17 05:06 PM
Sheffield Holly RPresident, CSIDec 16 '25Buy80.751,23099,32239,052Dec 16 06:36 PM
White Albert G IIIPresident & CEODec 16 '25Buy80.8010,000808,000236,151Dec 16 06:36 PM
Kurzius Lawrence ErikDirectorSep 29 '25Buy68.392,000136,7805,777Sep 29 08:36 PM
White Albert G IIIPresident & CEOSep 05 '25Buy68.3910,000683,900226,151Sep 05 05:10 PM
Warner Gerard H IIIPresident, CooperVision, Inc.Sep 05 '25Buy69.231,450100,38418,319Sep 05 04:07 PM
McBride Daniel GEVP & Chief Operating OfficerSep 02 '25Buy65.043,000195,12063,120Sep 02 05:17 PM
Andrews Brian GEVP, CFO & TreasurerSep 02 '25Buy65.681,525100,16222,191Sep 02 05:16 PM